1. Home
  2. Category
  3. Treatment Types

Oral Anticancer Agents

Online Exclusive Article

Management of Steroid-Induced Hyperglycemia in Hospitalized Patients With Cancer: A Review

Veronica J. Brady
Deanna Grimes
Terri Armstrong
Geri LoBiondo-Wood
ONF 2014, 41(6), E355-E365 DOI: 10.1188/14.ONF.E355-E365
Problem Identification: Glucocorticoids are prescribed for hospitalized patients with cancer for a variety of reasons, including cerebral edema, treatment and prevention of nausea, and as part of cancer treatment regimens. Glucocorticoids are known to cause hyperglycemia. The purpose of this study...
2
Average: 2 (1 vote)
Read this Article
Oncology Essentials

Bioavailability of Tyrosine Kinase Inhibitors: An Added Component of Assessment

Kristine Deano Abueg
CJON 2014, 18(6), 714-716 DOI: 10.1188/14.CJON.714-716
The growing prominence of tyrosine kinase inhibitors (TKIs) as treatment for malignancies prompts oncology nurses to expand the scope of their patient assessment. Because TKIs as oral agents have a different bioavailability than parenteral agents, factors that alter drug absorption and metabolism...
0
No votes yet
Read this Article
Online Exclusive Article

Essentials of Oral Oncolytics: Developing a Nursing Reference

Jennifer Matthews
Patricia Holland Caprera
CJON 2014, 18(5), E88-E92 DOI: 10.1188/14.CJON.E88-E92
A convenience sample of oncology clinicians from 17 practices throughout the northeastern United States participated in roundtable discussions. Discussions about oral adherence were initiated in multiple practices, and attendees were asked to describe what resources they currently use and what...
0
No votes yet
Read this Article
Online Exclusive Article

Ribavirin: The Need for Exposure Precautions

Kathy Mooney
Mary Melvin
Tracy Douglas
CJON 2014, 18(5), E93-E96 DOI: 10.1188/14.CJON.E93-E96
Ribavirin is used in the treatment of respiratory syncytial virus (RSV) in high-risk patients, including patients who have undergone hematopoietic stem cell transplantation, to reduce mortality from RSV pneumonia. It is classified as a hazardous drug with potential for carcinogenicity and...
0
No votes yet
Read this Article
Safety

Oral Antineoplastics in Nononcology Units: Moving Toward Safer Ordering, Administration, and Handling

Kathy Leifeste
CJON 2014, 18(4), 411-413 DOI: 10.1188/14.CJON.411-413
About 25% of all chemotherapy agents prescribed for patients with cancer are oral formulations. As a result, more patients in the acute care setting and tertiary care settings are receiving oral chemotherapy agents on nononcology units. This creates concerns about safe handling for patients,...
0
No votes yet
Read this Article

Related e-Books

View More

Questions, Concerns or Requests

We're just a click away for assistance.